ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)

Novartis CEO Vas Narasimhan warns that proposed U.S. Treasury investment limits on China could hinder moving technologies between U.S. and Chinese operations. He states finding new cancer or heart disease treatments is not a national security issue and patients in both nations ought to have access to discoveries.
Tap to vote and see what everyone thinks.
Summary by ByteBrief